ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
82,009.70
1.20%
S&P 500
5,521.52
-1.39%
Dow Jones
40,813.57
-1.30%
US Dollar vs Yen
148.7745
0.55%
Brent Oil
70.355
0.61%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Design Therapeutics Inc (DSGN) 銘柄情報

Design Therapeutics Inc

Design Therapeutics Inc (DSGN)

NASDAQ
4.72
0.00
(0.00%)
終了 3月14日 5:00AM
15分遅延
0.00
0.00
(0.00%)
取引時間後: -
15分遅延

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
4.72
買値
4.16
売値
4.79
出来高
-
0.00 日の範囲 0.00
2.4501 52 週間の範囲 7.77
時価総額
267.251M
前日終値
4.72
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
178,043
発行済株式数
56,621,037
配当利回り
-
PER
-4.02
1 株当たり利益 (EPS)
-1.18
歳入
-
純利益
-66.86M

Design Therapeutics Inc について

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.designtx.com
本社
Wilmington, Delaware, USA
設立
-
Design Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker DSGN. The last closing price for Design Therapeutics was US$4.72. Over the last year, Design Therapeutics shares have traded in a share price range of US$ 2.4501 to US$ 7.77.

Design Therapeutics currently has 56,621,037 shares in issue. The market capitalisation of Design Therapeutics is US$267.25 million. Design Therapeutics has a price to earnings ratio (PE ratio) of -4.02.

DSGN 最新ニュース

その他のニュース

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
2025年3月10日
DSGN (0.00%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
2025年3月10日
DSGN (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
2025年3月10日
DSGN (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
2025年1月13日
DSGN (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
2025年1月7日
DSGN (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
2025年1月7日
DSGN (0.00%)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.41-7.992202729045.135.5554.58821266044.94833142CS
40.81520.87067861723.9055.5553.9051959064.82317935CS
12-1.17-19.86417657055.896.813.581780434.9895503CS
26-0.85-15.26032315985.577.773.581765385.45002345CS
52273.52941176472.727.772.45012267864.74119523CS
156-12.67-72.857964347317.3926.31.943492526.68004362CS
260-23.28-83.142857142928501.943008698.33460647CS

DSGN - Frequently Asked Questions (FAQ)

What is the current Design Therapeutics share price?
The current share price of Design Therapeutics is US$ 4.72
How many Design Therapeutics shares are in issue?
Design Therapeutics has 56,621,037 shares in issue
What is the market cap of Design Therapeutics?
The market capitalisation of Design Therapeutics is USD 267.25M
What is the 1 year trading range for Design Therapeutics share price?
Design Therapeutics has traded in the range of US$ 2.4501 to US$ 7.77 during the past year
What is the PE ratio of Design Therapeutics?
The price to earnings ratio of Design Therapeutics is -4.02
What is the reporting currency for Design Therapeutics?
Design Therapeutics reports financial results in USD
What is the latest annual profit for Design Therapeutics?
The latest annual profit of Design Therapeutics is USD -66.86M
What is the registered address of Design Therapeutics?
The registered address for Design Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Design Therapeutics website address?
The website address for Design Therapeutics is www.designtx.com
Which industry sector does Design Therapeutics operate in?
Design Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.475
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.93
(0.00%)
0
AACGATA Creativity Global
US$ 0.9463
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.06
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.475
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.93
(0.00%)
0
AACGATA Creativity Global
US$ 0.9463
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.06
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.475
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.93
(0.00%)
0
AACGATA Creativity Global
US$ 0.9463
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.06
(0.00%)
0

DSGN Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
DSGN
Design Therapeutics
ASX
ARM
Aurora Minerals
NASDAQ
FSTP
F Stop
USOTC
ATEYY
Advantest (PK)
FTSE
EB4010
FTSEurofirst 300 Eurozon...
USOTC
ADPPF
Adler (CE)
USOTC
PNNCU
Pinnacle Ethanol (GM)
USOTC
AIPXF
Airport Facilities (PK)
BOV
BRSR6
BANRISUL PNB
NASDAQ
RDAC
Rising Dragon Acquisition
USOTC
ALHDF
Alco (PK)
TG
CPZ1
Cousins Properties
BOV
EALT3
AÇO ALTONA ON
USOTC
ARRJF
ARJO AB (PK)
NASDAQ
FBROX
Agf Global Select Fund S...
NASDAQ
SGMO
Sangamo Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す